nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2B6—Ifosfamide—testicular cancer	0.167	0.257	CbGbCtD
Pethidine—CYP2C19—Ifosfamide—testicular cancer	0.106	0.163	CbGbCtD
Pethidine—CYP2B6—Cisplatin—testicular cancer	0.0814	0.125	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—testicular cancer	0.0546	0.0838	CbGbCtD
Pethidine—ALB—Methotrexate—testicular cancer	0.0518	0.0796	CbGbCtD
Pethidine—CYP3A4—Ifosfamide—testicular cancer	0.0514	0.079	CbGbCtD
Pethidine—CYP2D6—Vinblastine—testicular cancer	0.0429	0.0659	CbGbCtD
Pethidine—CYP3A4—Vinblastine—testicular cancer	0.0273	0.0419	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—testicular cancer	0.0264	0.0405	CbGbCtD
Pethidine—CYP3A4—Etoposide—testicular cancer	0.0246	0.0378	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—testicular cancer	0.0168	0.0257	CbGbCtD
Pethidine—Flushing—Dactinomycin—testicular cancer	0.00148	0.00425	CcSEcCtD
Pethidine—Vasodilation procedure—Epirubicin—testicular cancer	0.00147	0.00421	CcSEcCtD
Pethidine—Vasodilation—Epirubicin—testicular cancer	0.00147	0.00421	CcSEcCtD
Pethidine—Injection site pain—Doxorubicin—testicular cancer	0.00146	0.00419	CcSEcCtD
Pethidine—Hallucination—Ifosfamide—testicular cancer	0.00146	0.00417	CcSEcCtD
Pethidine—Visual impairment—Ifosfamide—testicular cancer	0.00141	0.00404	CcSEcCtD
Pethidine—Erythema—Dactinomycin—testicular cancer	0.00139	0.00399	CcSEcCtD
Pethidine—Delirium—Doxorubicin—testicular cancer	0.00139	0.00398	CcSEcCtD
Pethidine—Anorexia—Vinblastine—testicular cancer	0.00137	0.00394	CcSEcCtD
Pethidine—Dyskinesia—Epirubicin—testicular cancer	0.00137	0.00394	CcSEcCtD
Pethidine—Decreased appetite—Chlorambucil—testicular cancer	0.00137	0.00392	CcSEcCtD
Pethidine—Vasodilation—Doxorubicin—testicular cancer	0.00136	0.0039	CcSEcCtD
Pethidine—Vasodilation procedure—Doxorubicin—testicular cancer	0.00136	0.0039	CcSEcCtD
Pethidine—Flushing—Ifosfamide—testicular cancer	0.00136	0.00389	CcSEcCtD
Pethidine—Depressed level of consciousness—Methotrexate—testicular cancer	0.00133	0.00382	CcSEcCtD
Pethidine—Coordination abnormal—Epirubicin—testicular cancer	0.00131	0.00377	CcSEcCtD
Pethidine—Feeling abnormal—Chlorambucil—testicular cancer	0.0013	0.00371	CcSEcCtD
Pethidine—Bradycardia—Cisplatin—testicular cancer	0.00129	0.00368	CcSEcCtD
Pethidine—Erythema—Ifosfamide—testicular cancer	0.00127	0.00365	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—testicular cancer	0.00127	0.00364	CcSEcCtD
Pethidine—Coma—Methotrexate—testicular cancer	0.00126	0.00361	CcSEcCtD
Pethidine—Decreased appetite—Vinblastine—testicular cancer	0.00125	0.00359	CcSEcCtD
Pethidine—Urticaria—Chlorambucil—testicular cancer	0.00125	0.00358	CcSEcCtD
Pethidine—Constipation—Vinblastine—testicular cancer	0.00123	0.00353	CcSEcCtD
Pethidine—Confusional state—Bleomycin—testicular cancer	0.00123	0.00352	CcSEcCtD
Pethidine—Anaphylactic shock—Bleomycin—testicular cancer	0.00122	0.00349	CcSEcCtD
Pethidine—Oedema—Bleomycin—testicular cancer	0.00122	0.00349	CcSEcCtD
Pethidine—Visual impairment—Cisplatin—testicular cancer	0.00122	0.00349	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—testicular cancer	0.00122	0.00349	CcSEcCtD
Pethidine—Feeling abnormal—Vinblastine—testicular cancer	0.00119	0.0034	CcSEcCtD
Pethidine—Coma—Epirubicin—testicular cancer	0.00118	0.00338	CcSEcCtD
Pethidine—Flushing—Cisplatin—testicular cancer	0.00117	0.00336	CcSEcCtD
Pethidine—Agitation—Ifosfamide—testicular cancer	0.00117	0.00336	CcSEcCtD
Pethidine—Anorexia—Bleomycin—testicular cancer	0.00116	0.00332	CcSEcCtD
Pethidine—Hypersensitivity—Chlorambucil—testicular cancer	0.00116	0.00332	CcSEcCtD
Pethidine—Vertigo—Ifosfamide—testicular cancer	0.00115	0.00328	CcSEcCtD
Pethidine—Hypotension—Bleomycin—testicular cancer	0.00114	0.00326	CcSEcCtD
Pethidine—Oedema—Dactinomycin—testicular cancer	0.00114	0.00325	CcSEcCtD
Pethidine—Asthenia—Chlorambucil—testicular cancer	0.00113	0.00323	CcSEcCtD
Pethidine—Palpitations—Ifosfamide—testicular cancer	0.00113	0.00323	CcSEcCtD
Pethidine—Pruritus—Chlorambucil—testicular cancer	0.00111	0.00319	CcSEcCtD
Pethidine—Convulsion—Ifosfamide—testicular cancer	0.0011	0.00316	CcSEcCtD
Pethidine—Hypertension—Ifosfamide—testicular cancer	0.0011	0.00315	CcSEcCtD
Pethidine—Erythema—Cisplatin—testicular cancer	0.0011	0.00315	CcSEcCtD
Pethidine—Coma—Doxorubicin—testicular cancer	0.00109	0.00313	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—testicular cancer	0.00109	0.00312	CcSEcCtD
Pethidine—Anorexia—Dactinomycin—testicular cancer	0.00108	0.0031	CcSEcCtD
Pethidine—Flushing—Etoposide—testicular cancer	0.00107	0.00308	CcSEcCtD
Pethidine—Hypersensitivity—Vinblastine—testicular cancer	0.00106	0.00304	CcSEcCtD
Pethidine—Decreased appetite—Bleomycin—testicular cancer	0.00106	0.00303	CcSEcCtD
Pethidine—Visual disturbance—Methotrexate—testicular cancer	0.00106	0.00303	CcSEcCtD
Pethidine—Muscle spasms—Cisplatin—testicular cancer	0.00106	0.00303	CcSEcCtD
Pethidine—Confusional state—Ifosfamide—testicular cancer	0.00105	0.00301	CcSEcCtD
Pethidine—Oedema—Ifosfamide—testicular cancer	0.00104	0.00298	CcSEcCtD
Pethidine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00104	0.00298	CcSEcCtD
Pethidine—Asthenia—Vinblastine—testicular cancer	0.00103	0.00296	CcSEcCtD
Pethidine—Tremor—Cisplatin—testicular cancer	0.00103	0.00295	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—testicular cancer	0.00101	0.00288	CcSEcCtD
Pethidine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00101	0.00288	CcSEcCtD
Pethidine—Feeling abnormal—Bleomycin—testicular cancer	0.001	0.00287	CcSEcCtD
Pethidine—Vomiting—Chlorambucil—testicular cancer	0.001	0.00287	CcSEcCtD
Pethidine—Anorexia—Ifosfamide—testicular cancer	0.000992	0.00284	CcSEcCtD
Pethidine—Decreased appetite—Dactinomycin—testicular cancer	0.000987	0.00283	CcSEcCtD
Pethidine—Hypotension—Ifosfamide—testicular cancer	0.000972	0.00279	CcSEcCtD
Pethidine—Muscle spasms—Etoposide—testicular cancer	0.000968	0.00277	CcSEcCtD
Pethidine—Urticaria—Bleomycin—testicular cancer	0.000967	0.00277	CcSEcCtD
Pethidine—Irritability—Methotrexate—testicular cancer	0.000956	0.00274	CcSEcCtD
Pethidine—Dizziness—Vinblastine—testicular cancer	0.000953	0.00273	CcSEcCtD
Pethidine—Convulsion—Cisplatin—testicular cancer	0.000952	0.00273	CcSEcCtD
Pethidine—Mood swings—Methotrexate—testicular cancer	0.000949	0.00272	CcSEcCtD
Pethidine—Feeling abnormal—Dactinomycin—testicular cancer	0.000935	0.00268	CcSEcCtD
Pethidine—Nausea—Chlorambucil—testicular cancer	0.000934	0.00268	CcSEcCtD
Pethidine—Anxiety—Cisplatin—testicular cancer	0.000932	0.00267	CcSEcCtD
Pethidine—Somnolence—Ifosfamide—testicular cancer	0.000925	0.00265	CcSEcCtD
Pethidine—Affect lability—Epirubicin—testicular cancer	0.000922	0.00264	CcSEcCtD
Pethidine—Vomiting—Vinblastine—testicular cancer	0.000916	0.00263	CcSEcCtD
Pethidine—Vertigo—Etoposide—testicular cancer	0.000904	0.00259	CcSEcCtD
Pethidine—Decreased appetite—Ifosfamide—testicular cancer	0.000904	0.00259	CcSEcCtD
Pethidine—Headache—Vinblastine—testicular cancer	0.000903	0.00259	CcSEcCtD
Pethidine—Oedema—Cisplatin—testicular cancer	0.000897	0.00257	CcSEcCtD
Pethidine—Anaphylactic shock—Cisplatin—testicular cancer	0.000897	0.00257	CcSEcCtD
Pethidine—Hypersensitivity—Bleomycin—testicular cancer	0.000897	0.00257	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—testicular cancer	0.000891	0.00255	CcSEcCtD
Pethidine—Constipation—Ifosfamide—testicular cancer	0.00089	0.00255	CcSEcCtD
Pethidine—Mood swings—Epirubicin—testicular cancer	0.000888	0.00254	CcSEcCtD
Pethidine—Loss of consciousness—Etoposide—testicular cancer	0.000885	0.00254	CcSEcCtD
Pethidine—Tachycardia—Cisplatin—testicular cancer	0.000875	0.00251	CcSEcCtD
Pethidine—Asthenia—Bleomycin—testicular cancer	0.000873	0.0025	CcSEcCtD
Pethidine—Convulsion—Etoposide—testicular cancer	0.000872	0.0025	CcSEcCtD
Pethidine—Hypertension—Etoposide—testicular cancer	0.000869	0.00249	CcSEcCtD
Pethidine—Hyperhidrosis—Cisplatin—testicular cancer	0.000867	0.00248	CcSEcCtD
Pethidine—Pruritus—Bleomycin—testicular cancer	0.000861	0.00247	CcSEcCtD
Pethidine—Feeling abnormal—Ifosfamide—testicular cancer	0.000857	0.00246	CcSEcCtD
Pethidine—Nausea—Vinblastine—testicular cancer	0.000856	0.00245	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—testicular cancer	0.000856	0.00245	CcSEcCtD
Pethidine—Anorexia—Cisplatin—testicular cancer	0.000855	0.00245	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—testicular cancer	0.000853	0.00245	CcSEcCtD
Pethidine—Hypotension—Cisplatin—testicular cancer	0.000838	0.0024	CcSEcCtD
Pethidine—Hypersensitivity—Dactinomycin—testicular cancer	0.000836	0.0024	CcSEcCtD
Pethidine—Confusional state—Etoposide—testicular cancer	0.000828	0.00237	CcSEcCtD
Pethidine—Urticaria—Ifosfamide—testicular cancer	0.000826	0.00237	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—testicular cancer	0.000824	0.00236	CcSEcCtD
Pethidine—Anaphylactic shock—Etoposide—testicular cancer	0.000822	0.00235	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—testicular cancer	0.000821	0.00235	CcSEcCtD
Pethidine—Asthenia—Dactinomycin—testicular cancer	0.000814	0.00233	CcSEcCtD
Pethidine—Tachycardia—Etoposide—testicular cancer	0.000802	0.0023	CcSEcCtD
Pethidine—Hyperhidrosis—Etoposide—testicular cancer	0.000794	0.00228	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000792	0.00227	CcSEcCtD
Pethidine—Anorexia—Etoposide—testicular cancer	0.000783	0.00224	CcSEcCtD
Pethidine—Decreased appetite—Cisplatin—testicular cancer	0.00078	0.00223	CcSEcCtD
Pethidine—Vomiting—Bleomycin—testicular cancer	0.000774	0.00222	CcSEcCtD
Pethidine—Drowsiness—Methotrexate—testicular cancer	0.000772	0.00221	CcSEcCtD
Pethidine—Hypotension—Etoposide—testicular cancer	0.000768	0.0022	CcSEcCtD
Pethidine—Rash—Bleomycin—testicular cancer	0.000767	0.0022	CcSEcCtD
Pethidine—Dermatitis—Bleomycin—testicular cancer	0.000767	0.0022	CcSEcCtD
Pethidine—Hypersensitivity—Ifosfamide—testicular cancer	0.000766	0.0022	CcSEcCtD
Pethidine—Asthenia—Ifosfamide—testicular cancer	0.000746	0.00214	CcSEcCtD
Pethidine—Sweating—Methotrexate—testicular cancer	0.00074	0.00212	CcSEcCtD
Pethidine—Feeling abnormal—Cisplatin—testicular cancer	0.000739	0.00212	CcSEcCtD
Pethidine—Pruritus—Ifosfamide—testicular cancer	0.000736	0.00211	CcSEcCtD
Pethidine—Somnolence—Etoposide—testicular cancer	0.00073	0.00209	CcSEcCtD
Pethidine—Nausea—Bleomycin—testicular cancer	0.000723	0.00207	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—testicular cancer	0.000722	0.00207	CcSEcCtD
Pethidine—Vomiting—Dactinomycin—testicular cancer	0.000722	0.00207	CcSEcCtD
Pethidine—Rash—Dactinomycin—testicular cancer	0.000716	0.00205	CcSEcCtD
Pethidine—Decreased appetite—Etoposide—testicular cancer	0.000714	0.00205	CcSEcCtD
Pethidine—Constipation—Etoposide—testicular cancer	0.000703	0.00201	CcSEcCtD
Pethidine—Sweating—Epirubicin—testicular cancer	0.000692	0.00198	CcSEcCtD
Pethidine—Dizziness—Ifosfamide—testicular cancer	0.000688	0.00197	CcSEcCtD
Pethidine—Feeling abnormal—Etoposide—testicular cancer	0.000677	0.00194	CcSEcCtD
Pethidine—Nausea—Dactinomycin—testicular cancer	0.000674	0.00193	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—testicular cancer	0.000668	0.00191	CcSEcCtD
Pethidine—Visual impairment—Methotrexate—testicular cancer	0.000668	0.00191	CcSEcCtD
Pethidine—Vomiting—Ifosfamide—testicular cancer	0.000661	0.0019	CcSEcCtD
Pethidine—Hypersensitivity—Cisplatin—testicular cancer	0.000661	0.00189	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—testicular cancer	0.00066	0.00189	CcSEcCtD
Pethidine—Rash—Ifosfamide—testicular cancer	0.000656	0.00188	CcSEcCtD
Pethidine—Dermatitis—Ifosfamide—testicular cancer	0.000655	0.00188	CcSEcCtD
Pethidine—Urticaria—Etoposide—testicular cancer	0.000653	0.00187	CcSEcCtD
Pethidine—Asthenia—Cisplatin—testicular cancer	0.000643	0.00184	CcSEcCtD
Pethidine—Sweating—Doxorubicin—testicular cancer	0.000641	0.00184	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—testicular cancer	0.000625	0.00179	CcSEcCtD
Pethidine—Nausea—Ifosfamide—testicular cancer	0.000618	0.00177	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—testicular cancer	0.000611	0.00175	CcSEcCtD
Pethidine—Hypersensitivity—Etoposide—testicular cancer	0.000605	0.00173	CcSEcCtD
Pethidine—Erythema—Methotrexate—testicular cancer	0.000603	0.00173	CcSEcCtD
Pethidine—Flushing—Epirubicin—testicular cancer	0.000602	0.00172	CcSEcCtD
Pethidine—Asthenia—Etoposide—testicular cancer	0.000589	0.00169	CcSEcCtD
Pethidine—Pruritus—Etoposide—testicular cancer	0.000581	0.00167	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—testicular cancer	0.000578	0.00166	CcSEcCtD
Pethidine—Vomiting—Cisplatin—testicular cancer	0.00057	0.00163	CcSEcCtD
Pethidine—Rash—Cisplatin—testicular cancer	0.000565	0.00162	CcSEcCtD
Pethidine—Dermatitis—Cisplatin—testicular cancer	0.000565	0.00162	CcSEcCtD
Pethidine—Erythema—Epirubicin—testicular cancer	0.000564	0.00162	CcSEcCtD
Pethidine—Flushing—Doxorubicin—testicular cancer	0.000557	0.0016	CcSEcCtD
Pethidine—Dizziness—Etoposide—testicular cancer	0.000543	0.00156	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—testicular cancer	0.000543	0.00155	CcSEcCtD
Pethidine—Vertigo—Methotrexate—testicular cancer	0.000542	0.00155	CcSEcCtD
Pethidine—Nausea—Cisplatin—testicular cancer	0.000533	0.00153	CcSEcCtD
Pethidine—Convulsion—Methotrexate—testicular cancer	0.000522	0.0015	CcSEcCtD
Pethidine—Vomiting—Etoposide—testicular cancer	0.000522	0.0015	CcSEcCtD
Pethidine—Erythema—Doxorubicin—testicular cancer	0.000522	0.0015	CcSEcCtD
Pethidine—Agitation—Epirubicin—testicular cancer	0.000519	0.00149	CcSEcCtD
Pethidine—Rash—Etoposide—testicular cancer	0.000518	0.00148	CcSEcCtD
Pethidine—Dermatitis—Etoposide—testicular cancer	0.000518	0.00148	CcSEcCtD
Pethidine—Headache—Etoposide—testicular cancer	0.000515	0.00147	CcSEcCtD
Pethidine—Vertigo—Epirubicin—testicular cancer	0.000507	0.00145	CcSEcCtD
Pethidine—Syncope—Epirubicin—testicular cancer	0.000506	0.00145	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—testicular cancer	0.000502	0.00144	CcSEcCtD
Pethidine—Palpitations—Epirubicin—testicular cancer	0.000499	0.00143	CcSEcCtD
Pethidine—Confusional state—Methotrexate—testicular cancer	0.000496	0.00142	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—testicular cancer	0.000496	0.00142	CcSEcCtD
Pethidine—Anaphylactic shock—Methotrexate—testicular cancer	0.000492	0.00141	CcSEcCtD
Pethidine—Convulsion—Epirubicin—testicular cancer	0.000489	0.0014	CcSEcCtD
Pethidine—Nausea—Etoposide—testicular cancer	0.000488	0.0014	CcSEcCtD
Pethidine—Hypertension—Epirubicin—testicular cancer	0.000487	0.0014	CcSEcCtD
Pethidine—Agitation—Doxorubicin—testicular cancer	0.00048	0.00137	CcSEcCtD
Pethidine—Anxiety—Epirubicin—testicular cancer	0.000479	0.00137	CcSEcCtD
Pethidine—Hyperhidrosis—Methotrexate—testicular cancer	0.000476	0.00136	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—testicular cancer	0.00047	0.00135	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—testicular cancer	0.000469	0.00134	CcSEcCtD
Pethidine—Anorexia—Methotrexate—testicular cancer	0.000469	0.00134	CcSEcCtD
Pethidine—Syncope—Doxorubicin—testicular cancer	0.000468	0.00134	CcSEcCtD
Pethidine—Confusional state—Epirubicin—testicular cancer	0.000464	0.00133	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—testicular cancer	0.000461	0.00132	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—testicular cancer	0.000461	0.00132	CcSEcCtD
Pethidine—Oedema—Epirubicin—testicular cancer	0.000461	0.00132	CcSEcCtD
Pethidine—Hypotension—Methotrexate—testicular cancer	0.00046	0.00132	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—testicular cancer	0.000459	0.00132	CcSEcCtD
Pethidine—Shock—Epirubicin—testicular cancer	0.000453	0.0013	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—testicular cancer	0.000452	0.0013	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—testicular cancer	0.000451	0.00129	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—testicular cancer	0.000449	0.00129	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—testicular cancer	0.000445	0.00128	CcSEcCtD
Pethidine—Insomnia—Methotrexate—testicular cancer	0.000445	0.00128	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—testicular cancer	0.000443	0.00127	CcSEcCtD
Pethidine—Anorexia—Epirubicin—testicular cancer	0.000439	0.00126	CcSEcCtD
Pethidine—Somnolence—Methotrexate—testicular cancer	0.000437	0.00125	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—testicular cancer	0.000435	0.00125	CcSEcCtD
Pethidine—Hypotension—Epirubicin—testicular cancer	0.00043	0.00123	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—testicular cancer	0.00043	0.00123	CcSEcCtD
Pethidine—Decreased appetite—Methotrexate—testicular cancer	0.000428	0.00123	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000426	0.00122	CcSEcCtD
Pethidine—Oedema—Doxorubicin—testicular cancer	0.000426	0.00122	CcSEcCtD
Pethidine—Shock—Doxorubicin—testicular cancer	0.000419	0.0012	CcSEcCtD
Pethidine—Insomnia—Epirubicin—testicular cancer	0.000417	0.00119	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—testicular cancer	0.000416	0.00119	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000412	0.00118	CcSEcCtD
Pethidine—Somnolence—Epirubicin—testicular cancer	0.000409	0.00117	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—testicular cancer	0.000406	0.00116	CcSEcCtD
Pethidine—Feeling abnormal—Methotrexate—testicular cancer	0.000406	0.00116	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—testicular cancer	0.0004	0.00115	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—testicular cancer	0.000398	0.00114	CcSEcCtD
Pethidine—Constipation—Epirubicin—testicular cancer	0.000394	0.00113	CcSEcCtD
Pethidine—Urticaria—Methotrexate—testicular cancer	0.000391	0.00112	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—testicular cancer	0.000385	0.0011	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—testicular cancer	0.00038	0.00109	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—testicular cancer	0.000379	0.00109	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—testicular cancer	0.00037	0.00106	CcSEcCtD
Pethidine—Urticaria—Epirubicin—testicular cancer	0.000366	0.00105	CcSEcCtD
Pethidine—Constipation—Doxorubicin—testicular cancer	0.000364	0.00104	CcSEcCtD
Pethidine—Hypersensitivity—Methotrexate—testicular cancer	0.000363	0.00104	CcSEcCtD
Pethidine—Asthenia—Methotrexate—testicular cancer	0.000353	0.00101	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—testicular cancer	0.000351	0.00101	CcSEcCtD
Pethidine—Pruritus—Methotrexate—testicular cancer	0.000348	0.000998	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—testicular cancer	0.000339	0.000972	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—testicular cancer	0.000339	0.00097	CcSEcCtD
Pethidine—Asthenia—Epirubicin—testicular cancer	0.00033	0.000947	CcSEcCtD
Pethidine—Pruritus—Epirubicin—testicular cancer	0.000326	0.000934	CcSEcCtD
Pethidine—Dizziness—Methotrexate—testicular cancer	0.000325	0.000933	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—testicular cancer	0.000314	0.0009	CcSEcCtD
Pethidine—Vomiting—Methotrexate—testicular cancer	0.000313	0.000897	CcSEcCtD
Pethidine—Rash—Methotrexate—testicular cancer	0.00031	0.000889	CcSEcCtD
Pethidine—Dermatitis—Methotrexate—testicular cancer	0.00031	0.000888	CcSEcCtD
Pethidine—Headache—Methotrexate—testicular cancer	0.000308	0.000883	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—testicular cancer	0.000306	0.000876	CcSEcCtD
Pethidine—Dizziness—Epirubicin—testicular cancer	0.000305	0.000873	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—testicular cancer	0.000301	0.000864	CcSEcCtD
Pethidine—Vomiting—Epirubicin—testicular cancer	0.000293	0.000839	CcSEcCtD
Pethidine—Nausea—Methotrexate—testicular cancer	0.000292	0.000838	CcSEcCtD
Pethidine—Rash—Epirubicin—testicular cancer	0.00029	0.000832	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—testicular cancer	0.00029	0.000831	CcSEcCtD
Pethidine—Headache—Epirubicin—testicular cancer	0.000289	0.000827	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—testicular cancer	0.000282	0.000807	CcSEcCtD
Pethidine—Nausea—Epirubicin—testicular cancer	0.000274	0.000784	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—testicular cancer	0.000271	0.000776	CcSEcCtD
Pethidine—Rash—Doxorubicin—testicular cancer	0.000269	0.00077	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—testicular cancer	0.000268	0.000769	CcSEcCtD
Pethidine—Headache—Doxorubicin—testicular cancer	0.000267	0.000765	CcSEcCtD
Pethidine—Nausea—Doxorubicin—testicular cancer	0.000253	0.000725	CcSEcCtD
